NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,732,000 | +7.0% | 19,800 | 0.0% | 0.75% | +1.9% |
| Q3 2021 | $1,619,000 | -10.4% | 19,800 | 0.0% | 0.74% | -11.6% |
| Q2 2021 | $1,807,000 | +6.7% | 19,800 | 0.0% | 0.83% | -0.7% |
| Q1 2021 | $1,693,000 | -9.5% | 19,800 | 0.0% | 0.84% | -12.8% |
| Q4 2020 | $1,870,000 | +8.6% | 19,800 | 0.0% | 0.96% | -5.5% |
| Q3 2020 | $1,722,000 | -0.4% | 19,800 | 0.0% | 1.02% | -4.5% |
| Q2 2020 | $1,729,000 | +5.9% | 19,800 | 0.0% | 1.07% | -16.7% |
| Q1 2020 | $1,633,000 | -12.9% | 19,800 | 0.0% | 1.28% | +12.2% |
| Q4 2019 | $1,875,000 | +8.9% | 19,800 | 0.0% | 1.14% | +10.1% |
| Q3 2019 | $1,721,000 | -4.8% | 19,800 | 0.0% | 1.04% | +7.0% |
| Q2 2019 | $1,808,000 | -5.0% | 19,800 | 0.0% | 0.97% | -5.7% |
| Q1 2019 | $1,904,000 | +12.1% | 19,800 | 0.0% | 1.03% | -0.5% |
| Q4 2018 | $1,699,000 | -0.4% | 19,800 | 0.0% | 1.03% | +16.0% |
| Q3 2018 | $1,706,000 | +14.0% | 19,800 | 0.0% | 0.89% | -0.1% |
| Q2 2018 | $1,496,000 | – | 19,800 | – | 0.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |